The CD19 surface antigen plays a critical role in B-cell development and maturation [1,2], and elevated levels of CD19 can lead to B-cell malignancies such as acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and B-cell lymphomas [3]. Here, CD19 is linked to acute lymphoblastic leukemia.